Asset Management One Co., Ltd. Vertex Pharmaceuticals Inc Transaction History

Asset Management One Co., Ltd.

$28.2 Billion
Q4 2024

A detailed history of Asset Management One Co., Ltd. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 135,283 shares of VRTX stock, worth $62.5 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

135,283

Previous 135,187 0.07%

Holding current value

$62.5 Million

Previous $62.9 Million 13.35%

% of portfolio

0.19%

Previous 0.23%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$396.64 - $516.74 $38,077 - $49,607	96 Added 0.07%	135,283 $54.5 Million
Q3 2024 Oct 30, 2024	BUY	$460.0 - $505.78 $656,420 - $721,748	1,427 Added 1.07%	135,187 $62.9 Million
Q2 2024 Jul 18, 2024	SELL	$392.81 - $485.53 $1.98 Million - $2.45 Million	-5,049 Reduced 3.64%	133,760 $62.7 Million
Q1 2024 May 02, 2024	SELL	$407.69 - $446.08 $1.57 Million - $1.72 Million	-3,848 Reduced 2.7%	138,809 $58 Million
Q4 2023 Jan 24, 2024	BUY	$343.0 - $410.68 $5.68 Million - $6.8 Million	16,559 Added 13.13%	142,657 $58 Million
Q3 2023 Oct 19, 2023	BUY	$338.18 - $362.46 $126,817 - $135,922	375 Added 0.3%	126,098 $43.8 Million
Q2 2023 Jul 31, 2023	SELL	$314.42 - $351.91 $374,159 - $418,772	-1,190 Reduced 0.94%	125,723 $44.2 Million
Q1 2023 Apr 25, 2023	BUY	$283.23 - $323.1 $2.26 Million - $2.58 Million	7,978 Added 6.71%	126,913 $40 Million
Q4 2022 Feb 06, 2023	SELL	$285.76 - $321.48 $2.04 Million - $2.29 Million	-7,130 Reduced 5.66%	118,935 $34.3 Million
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $856,814 - $956,003	-3,129 Reduced 2.42%	126,065 $36.5 Million
Q2 2022 Jul 29, 2022	SELL	$234.96 - $292.55 $6.07 Million - $7.55 Million	-25,819 Reduced 16.66%	129,194 $36.4 Million
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $3.39 Million - $4 Million	-15,309 Reduced 8.99%	155,013 $40.5 Million
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $2.37 Million - $2.99 Million	13,382 Added 8.53%	170,322 $38 Million
Q3 2021 Nov 02, 2021	SELL	$181.39 - $202.99 $976,059 - $1.09 Million	-5,381 Reduced 3.32%	156,940 $28.5 Million
Q2 2021 Aug 03, 2021	BUY	$187.49 - $221.1 $900,139 - $1.06 Million	4,801 Added 3.05%	162,321 $32.7 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $448,612 - $522,918	-2,167 Reduced 1.36%	157,520 $33.8 Million
Q4 2020 Feb 12, 2021	BUY	$207.01 - $276.09 $4.48 Million - $5.98 Million	21,644 Added 15.68%	159,687 $37.3 Million
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $1.03 Million - $1.22 Million	-4,034 Reduced 2.84%	138,043 $37.6 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $218,715 - $286,926	970 Added 0.69%	142,077 $41.2 Million
Q1 2020 May 14, 2020	SELL	$199.77 - $247.81 $65,724 - $81,529	-329 Reduced 0.23%	141,107 $33.6 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $95,024 - $127,628	570 Added 0.4%	141,436 $31 Million
Q3 2019 Nov 14, 2019	BUY	$166.23 - $187.09 $659,933 - $742,747	3,970 Added 2.9%	140,866 $23.9 Million
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $1.94 Million - $2.24 Million	11,789 Added 9.42%	136,896 $25.1 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $47.8 Million - $56.9 Million	-292,016 Reduced 70.01%	125,107 $23 Million
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $237,891 - $301,000	1,566 Added 0.38%	417,123 $69 Million
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $266,858 - $306,649	-1,591 Reduced 0.38%	415,557 $80 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $3.27 Million - $3.81 Million	22,425 Added 5.68%	417,148 $70.2 Million
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $752,845 - $879,627	4,966 Added 1.27%	394,723 $64.3 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $199,879 - $226,480	-1,456 Reduced 0.37%	389,757 $58.4 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $1.17 Million - $1.28 Million	7,896 Added 2.06%	391,213 $59.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	383,317	383,317 $49.4 Million

Others Institutions Holding VRTX

# of Institutions

1,705

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.

Account

Asset Management One Co., Ltd. Vertex Pharmaceuticals Inc Transaction History